Clinical Trial: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Primary Membranous Nephropathy
Study Type: INTERVENTIONAL
Official Title: A Phase 3 Superiority Study Comparing the Safety and Efficacy of SNP-ACTH (1-39) Gel Compared to Rituximab and FDA Approved Biosimilars in Adults With Primary Membranous Nephropathy (PMN) in a Two-Pha
Brief Summary:
The goal of the Phase 3a part of this clinical trial is to determine the optimal dose that will be used in the Phase 3b part of this clinical trial.The goal of the Phase 3b part is to assess the efficacy of SNP-ACTH (1-39) Gel relative to rituximab in patients with primary membranous nephropathy (PMN) at month 24.
Read more